In our study, we found a higher significant increase in the serum levels of AK155(IL-26) in COPD patients in comparison with the control group and exacerbated COPD patients in comparison with the stable group; this result matched findings by Lundgren et al. [49] who showed similar results. Here, IL26 is linked to chronic obstructive pulmonary disease.